Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Y. Arkam · SciRah

Researcher profile · Semantic Scholar

Y. Arkam

Share profile

Y. Arkam — researcher profile on SciRah

h-index: 8
Works: 21
Citations: 334

Most-cited papers

Commercial anti‐CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center
P. Sesques, E. Ferrant, V. Safar, F. Wallet +32 more
2020American journal of hematology/oncology130 citations Open access
Semantic Scholar
Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct.
S. Pasquet, H. Sovalat, P. Henon, N. Bischoff +7 more
2009Cytotherapy48 citations
Semantic Scholar
A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma
R. Gressin, N. Daguindau, A. Tempescul, A. Moreau +36 more
2018Haematologica45 citations Open access
Semantic Scholar
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial
F. Guilhot, Françoise Rigal-Huguet, J. Guilhot, A. Guerci-Bresler +51 more
2021Leukemia25 citations
Semantic Scholar
Frontline Therapy with the Ribvd Regimen Elicits High Clinical and Molecular Response Rates and Long PFS in Elderly Patients Mantle Cell Lymphoma (MCL); Final Results of a Prospective Phase II Trial By the Lysa Group
R. Gressin, M. Callanan, N. Daguindau, A. Tempescul +34 more
201423 citations
Semantic Scholar
Role of the CD34+38− cells in posttransplant hematopoietic recovery
P. Hénon, H. Sovalat, E. Wunder, M. Ojeda-Uribe +5 more
1998Stem Cells22 citations Open access
Semantic Scholar
How to Treat Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Patients : Results on 86 Patients of the French BPDCN Network
E. Poret, C. Vidal, Y. Desbrosses, F. Delettre +43 more
201511 citations Open access
Semantic Scholar
Has the Prognostic of Primary Plasma Cell Leukemia Improved with New drugs
D. Chaoui, X. Leleu, M. Roussel, B. Royer +9 more
20099 citations
Semantic Scholar
The Ribvd Regimen (Rituximab IV, Bendamustine IV, Velcade SC, Dexamethasone IV) Offers a High Complete Response Rate In Elderly Patients With Untreated Mantle Cell Lymphoma. Preliminary Results Of The Lysa Trial “Lymphome Du Manteau 2010 SA”
M. Callanan, N. Daguindau, A. Tempescul, S. Carras +34 more
20138 citations
Semantic Scholar
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group
S. Carras, Alexia Torroja, A. Emadali, E. Montaut +39 more
2023Haematologica5 citations Open access
Semantic Scholar
Relapsed chronic lymphocytic leukemia retreated with rituximab: interim results of the PERLE study
D. Chaoui, S. Choquet, L. Sanhes, B. Mahé +14 more
2017Leukemia and Lymphoma5 citations
Semantic Scholar
Arsenic Trioxide (AS2O3) Therapy for Relapsed Acute Promyelocytic Leukemia (APL): Comparison with a Historic Control Combining All-Trans Retinoic Acid (ATRA) Plus Intensive Chemotherapy.
X. Thomas, A. Pigneux, E. Raffoux, F. Huguet +10 more
20053 citations
Semantic Scholar
Long‐term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in elderly mantle cell lymphoma patients. For the LYSA group.
S. Carras, A. Torroja, A. Emadali, N. Daguindau +38 more
2023Hematological Oncology0 citations Open access
Semantic Scholar
Dutcher bodies in a Waldenström Macroglobulinaemia patient.
Anne Checkouri, Carole Humbert, Y. Arkam, A. Debliquis
2023Annales de Biologie Clinique0 citations
Semantic Scholar
634.MYELOPROLIFERATIVE SYNDROMES: CLINICAL AND EPIDEMIOLOGICAL Impact of the COVID-19 Epidemic on Patients with Myeloproliferative Neoplasia: The French Prospective Observational Study Covim
Francois Perrard, D. Ranta, L. Roy, M. Ojeda-Uribe +20 more
20220 citations
Semantic Scholar
Impact of the COVID-19 Epidemic on Patients with Myeloproliferative Neoplasia: The French Prospective Observational Study Covim
L. Legros, Françoise Boyer Perrard, D. Ranta, L. Roy +23 more
2022Blood0 citations Open access
Semantic Scholar
Relapsed or refractory chronic lymphocytic leukemia retreated with rituximab in daily practice: final results of the PERLE study
D. Chaoui, M. Hacini, O. Fitoussi, Lionel Karlin +23 more
2019Leukemia and Lymphoma0 citations
Semantic Scholar
Long-term benefi t of intracardiac delivery of autologous granulocyte – colony-stimulating factor-mobilized blood CD 34 + cells containing cardiac progenitors on regional heart structure and function after myocardial infarct
S. Pasquet, H. Sovalat, P. Henon, N. Bischoff +7 more
20090 citations
Semantic Scholar
Intracardiac Transplantation of Already Specifically Dedifferentiated Circulating CD34+ Cell Subsets Would Favor Post-Ischemic Myocardial Regeneration.
P. Henon, Hanna Sovalat, M. Ojeda-Uribe, Y. Arkam +3 more
20040 citations
Semantic Scholar
Impact on Short and Long-Term Hematopoiesis of G-CSF Administered Posttransplant in Function of the Amounts of Peripheral Blood CD34 + 38 − Cells Reinfused.
P. Henon, Hanna Sovalat, M. Ojeda-Uribe, Y. Arkam +1 more
20040 citations
Semantic Scholar
Effect of cryopreservation on adhesion molecule expression in peripheral blood derived CD34+ cells
H. Sovalat, M. Ojeda, Y. Arkam, H. Lewandowsky +2 more
20000 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Ojeda-Uribe×7
Invite
M. Ojeda-Uribe — researcher profile on SciRah
V. Dorvaux×7
Invite
V. Dorvaux — researcher profile on SciRah
A. Tempescul×6
Invite
A. Tempescul — researcher profile on SciRah
F. Jardin×6
Invite
F. Jardin — researcher profile on SciRah

×6

Invite

L. Voillat — researcher profile on SciRah

Invite

B. Joly — researcher profile on SciRah

Invite

H. Zerazhi — researcher profile on SciRah

Invite

M. Alexis — researcher profile on SciRah

Invite

P. Henon — researcher profile on SciRah

N. Daguindau×5

Invite

N. Daguindau — researcher profile on SciRah

Invite

S. Carras — researcher profile on SciRah

Invite

R. Houot — researcher profile on SciRah